Search Results - "Dederichs, Juergen"

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial by Altman, Pablo, Wehbe, Luis, Dederichs, Juergen, Guerin, Tadhg, Ament, Brian, Moronta, Miguel Cardenas, Pino, Andrea Valeria, Goyal, Pankaj

“…The chronic and progressive nature of chronic obstructive pulmonary disease (COPD) requires self-administration of inhaled medication. Dry powder inhalers…”
Get full text

Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol by Pavkov, Richard, Mueller, Stefan, Fiebich, Katrin, Singh, Dilraj, Stowasser, Frank, Pignatelli, Giovanni, Walter, Benoît, Ziegler, Dominik, Dalvi, Mukul, Dederichs, Juergen, Rietveld, Ilse

“…Abstract Objective: To report performance characteristics and robustness of the Breezhaler* device, a new capsule based dry powder inhaler (DPI) with low…”
Get full text

Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD by Chapman, Kenneth R, Fogarty, Charles M, Peckitt, Clare, Lassen, Cheryl, Jadayel, Dalal, Dederichs, Juergen, Dalvi, Mukul, Kramer, Benjamin

“…For optimal efficacy, an inhaler should deliver doses consistently and be easy for patients to use with minimal instruction. The delivery characteristics,…”
Get full text

Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of Breezhaler and Respimat by O'Hagan, Philip, Dederichs, Juergen, Viswanad, Boomi, Gasser, Matthias, Walda, Susann

“…Good compliance in chronic obstructive pulmonary disease (COPD) is of 'paramount importance' in reducing the occurrence of acute exacerbations, hospitalisation…”
Get full text

Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD by Murphy, Lorraine, Rennard, Stephen, Donohue, James, Molimard, Mathieu, Dahl, Ronald, Beeh, Kai-Michael, Dederichs, Juergen, Fülle, Hans-Jürgen, Higgins, Mark, Young, David

“…Indacaterol is the first once-daily, long-acting β 2 -adrenergic agonist (LABA) approved for the treatment of chronic obstructive pulmonary disease (COPD)…”
Get full text

Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol by Pavkov, Richard, Mueller, Stefan, Fiebich, Katrin, Singh, Dilraj, Stowasser, Frank, Pignatelli, Giovanni, Walter, Benoît, Ziegler, Dominik, Dalvi, Mukul, Dederichs, Juergen, Rietveld, Ilse

“…To report performance characteristics and robustness of the Breezhaler device, a new capsule based dry powder inhaler (DPI) with low resistance (0.07 cm H 2 O…”
Get full text